Moderna mRNA Covid Vaccine

News

Moderna, COVID-19

Moderna gets full US approval for COVID shot in at-risk children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

BioSpace · 3d

Moderna Wins Full Approval for COVID-19 Shot for Higher-Risk Kids

The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory winning streak, which has also included nods for a next-gen COVID-19 vaccine and an RSV shot.

BioPharma Dive · 4d

Moderna COVID vaccine gets full approval for children

The approval comes amid regulatory upheaval under HHS head Robert F. Kennedy Jr., who has pushed for changes around mRNA vaccines in particular.

13d

Moderna says mRNA flu vaccine sailed through trial, beating standard shot

Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 ...

4don MSN

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Infectious Disease Advisor13h

Multicomponent Vaccine for COVID-19, Influenza Shows Promise in Phase 3 Trial

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Healio12d

Moderna reports positive phase 3 data for mRNA seasonal flu vaccine

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results